COMMUNIQUÉS West-GlobeNewswire

GENFIT Announces Publication of the 2025 Universal Registration Document
07/04/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 07, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025
07/04/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 07 avril 2026 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award
07/04/2026
ANAHEIM, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- American Botanical Council (ABC) presented Natural Remedies with the prestigious 2026 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award during [...]
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
07/04/2026
~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ WEXFORD, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/04/2026
Nantes, le 7 avril 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
IBA – ACQUISITION OF OWN SHARES
07/04/2026
Louvain-la-Neuve, Belgium, April 7 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
07/04/2026
Louvain-la-Neuve, Belgique, 7 avril 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
EssilorLuxottica: Disclosure of transactions in own shares
07/04/2026
Disclosure of transactions in own shares Paris, France (April 7, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that from [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
07/04/2026
Déclaration de transactions sur actions propres Paris, France (7 avril 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 1 er avril 2026 au [...]
HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification
07/04/2026
Rigorous training and certification gives clinicians a validated pathway to AI-enabled cardiac POCUS proficiency ROCKVILLE, Md. and BORDEAUX, France, April 07, 2026 (GLOBE NEWSWIRE) -- HeartFocus , the AI-enabled [...]
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test
07/04/2026
ORLANDO, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp f/k/a Exousia Pro, Inc. ( OTCPK: MAJI ), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is proud [...]
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
07/04/2026
Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international markets WELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE [...]
Regional Health Properties Reports Fourth Quarter 2025 Results
07/04/2026
Reported Full Year Profitability of $3.4 million Repurchased 511,099 Series B Preferred Shares HealthCare Services segment reports 20% growth in Average Daily Census ATLANTA, GA, April 07, 2026 (GLOBE NEWSWIRE) -- [...]
Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP
07/04/2026
BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Folia Health today announced a collaboration with argenx to launch a first-of-its-kind, at-home observational real-world evidence initiative supporting individuals living with [...]
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics
07/04/2026
ALLENTOWN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine today announced a preferred partnership with Roche Diagnostics. This partnership aligns HNL Lab Medicine with an organization that shares its focus on [...]
Inc. Recognizes U.S. Oral Surgery Management for Growth
07/04/2026
USOSM Ranked 90 on 2026 List of Fastest Growing Companies in the Southwest IRVING, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping [...]
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
07/04/2026
RESEARCH TRIANGLE PARK, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics today provided an update on recent communications with the U.S. Food and Drug Administration (FDA) related to its Investigational [...]
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
07/04/2026
TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) and BioXtek Inc. (“ [...]
Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™
07/04/2026
The First Shelf-Stable Lyophilized Amniotic Graft Containing HC-HA/PTX3 Designed for Efficient Workflow for Patients with Mild-to-Moderate Dry Eye ROSWELL, Ga., April 07, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc [...]

Pages